Literature DB >> 17364373

A new procedure of arytenoid adduction combined with type I thyroplasty under general anesthesia using a laryngeal mask.

Ryoji Tokashiki1, Hiroyuki Hiramatu, Kiyoaki Tsukahara, Hidenori Kanebayashi, Kazuhiro Nakamura, Rei Motohashi, Mamoru Suzuki.   

Abstract

Laryngeal framework surgery is usually performed under local anesthesia. However, some patients are unable to tolerate extended surgery. A case of an 82-year-old woman who underwent medialization thyroplasty and arytenoid adduction of direct lateral cricoarytenoid (LCA) muscle pulling at the same time under general anesthesia using a laryngeal mask is reported. Endoscopic observation through the laryngeal mask allows direct visual control of the vocal cord. The LCA pulling method does not touch the posterior border of the thyroid cartilage so that the laryngeal mask does not disturb the arytenoid adducts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364373     DOI: 10.1080/00016480600746289

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  Characterization of arytenoid vertical displacement in unilateral vocal fold paralysis by three-dimensional computed tomography.

Authors:  Hiroyuki Hiramatsu; Ryoji Tokashiki; Mari Nakamura; Rei Motohashi; Tomoyuki Yoshida; Mamoru Suzuki
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-04-24       Impact factor: 2.503

2.  Revision laryngeal framework surgery performed by directly pulling the lateral cricoarytenoid muscle.

Authors:  T Kanazawa; D Komazawa; Y Watanabe; K Ichimura
Journal:  J Laryngol Otol       Date:  2014-08-14       Impact factor: 1.469

3.  Usefulness of three-dimensional computed tomography of the larynx for evaluation of unilateral vocal fold paralysis before and after treatment: technique and clinical applications.

Authors:  Hiroyuki Hiramatsu; Ryoji Tokashiki; Mamoru Suzuki
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.